Prostate cancer patient‐derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens

Patient‐derived organoids (PDOs) represent promising preclinical models in various tumor types. In the context of prostate cancer (PCa), however, their establishment has been hampered by poor success rates, which impedes their broad use for translational research applications. Along with the necessi...

Descripción completa

Detalles Bibliográficos
Autores principales: Servant, Raphaëlle, Garioni, Michele, Vlajnic, Tatjana, Blind, Melanie, Pueschel, Heike, Müller, David C, Zellweger, Tobias, Templeton, Arnoud J, Garofoli, Andrea, Maletti, Sina, Piscuoglio, Salvatore, Rubin, Mark A, Seifert, Helge, Rentsch, Cyrill A, Bubendorf, Lukas, Le Magnen, Clémentine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2021
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361965/
https://www.ncbi.nlm.nih.gov/pubmed/33934365
http://dx.doi.org/10.1002/path.5698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361965/
https://www.ncbi.nlm.nih.gov/pubmed/33934365
http://dx.doi.org/10.1002/path.5698

Ejemplares similares